Home > Insider Trading > Filing (0001423774-24-000274)

Filing Details

Accession Number:: 0001423774-24-000274
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-21 16:16:54
Reporting Period:: 2024-11-06

Accepted Time:: 2024-11-21 16:16:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1423774	Zuora Inc	ZUO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235775	Jr D John Harkey	C/O Zuora, Inc. 101 Redwood Shores Parkway Redwood City CA 94065		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2024-11-06	236,218	$9.90	201,000	No	4	S	Indirect	By JDH Life Sciences, Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By JDH Life Sciences, Inc.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	43,567	Direct
Class A Common Stock	100,000	Indirect	By Abraxus Trust

Footnotes

Shares were sold by the Account Manager (as defined below) without the prior knowledge of the Reporting Person.
Represents the weighted average sale price. The lowest price at which shares were sold was $9.90 and the highest price at which shares were sold was $9.91. The Reporting Person undertakes to provide upon request to the staff of the U.S. Securities and Exchange Commission, Zuora or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth in this footnote.
Reporting Person is the president and sole beneficial owner of JDH Life Sciences, Inc., and may be deemed to share voting and dispositive power with regard to the shares held by JDH Life Sciences, Inc., with Scalar Gauge Management, LLC (the Account Manager).
Includes 40,567 Restricted Stock Units (RSUs) granted on April 30, 2024, upon the appointment of the Reporting Person to Zuora's Board of Directors. Each RSU represents a contingent right to receive one share of Zuora's Class A Common Stock upon settlement. The RSUs will vest and convert into shares of Zuora's Class A Common Stock as to 1/3rd of the total number of RSUs subject to the award on each of April 30, 2025, April 30, 2026, and April 30, 2027, in each case, so long as the Reporting Person continues to provide services to Zuora through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in Zuora's 2018 Equity Incentive Plan.
Reporting Person is the trustee and sole beneficiary of the Abraxus Trust and may be deemed to have sole voting and dispositive power with regard to the shares held by the Abraxus Trust.